Imaging volumes are climbing faster than radiology departments can hire. As workloads increase and resources remain limited, radiology teams need solutions that reduce repetitive work without adding complexity. Computer Vision AG <www.computervision.swiss> is developing Emeralgo <www.emeralgo.com>, an AI-powered platform for musculoskeletal MRI.
Emeralgo automatically analyzes relevant image information, structures findings and integrates seamlessly into existing clinical workflows, including PACS. Rather than replacing established systems or disrupting existing processes, Emeralgo supports radiologists directly within their familiar working environment. The platform is built on FDA 510(k)-cleared technology, combining intelligent image analysis with a strong focus on efficiency, consistency and clinical usability.
Computer Vision AG’s vision extends beyond a single application. Emeralgo is being developed as a scalable platform for musculoskeletal diagnostics, creating the foundation for broader applications and international growth.
Our mission is clear: to make AI a practical and trusted part of everyday radiology – supporting healthcare professionals and contributing to more efficient diagnostic workflows.
We invite healthcare providers, strategic partners and investors to join us in shaping the next generation of AI-powered radiology. Interested in becoming part of our journey? Learn more about investment opportunities: www.computervision.swiss
